human
respiratori
syncyti
viru
rsv
one
common
virus
infect
respiratori
tract
infant
rapid
sensit
detect
rsv
import
minim
incid
infect
studi
novel
monoclon
antibodi
mab
rsv
nucleoprotein
np
develop
appli
develop
rapid
fluoresc
immunochromatograph
strip
test
fict
employ
europium
nanoparticl
fluoresc
materi
fict
limit
detect
antigen
viru
tcid
ml
respect
correspond
mean
sd
rna
copi
number
per
reaction
mixtur
rsv
np
clinic
studi
reveal
sensit
specif
rsv
detect
compar
perform
revers
transcript
polymeras
chain
reaction
rtpcr
repres
improv
sensit
sd
biolin
rapid
kit
newli
develop
fict
could
use
tool
rapid
diagnosi
rsv
infect
worldwid
acut
respiratori
tract
infect
infanc
childhood
mainli
caus
human
respiratori
syncyti
viru
rsv
common
caus
bronchiol
pneumonia
among
children
age
year
nadir
concentr
protect
matern
immunoglobulin
g
igg
transfer
fetu
rsv
widespread
human
pathogen
immun
obtain
rsv
infect
might
protect
frequent
lead
reinfect
approxim
children
becom
infect
within
first
two
year
life
viru
frequent
reinfect
older
children
adult
major
patient
rsv
infect
develop
upper
respiratori
ill
signific
minor
present
lower
respiratori
tract
ill
predominantli
form
bronchiol
earli
diagnosi
rsv
infect
essenti
avail
method
diagnosi
use
respiratori
sampl
includ
viru
cultur
molecular
diagnost
molecular
assay
rapid
sensit
detect
rsv
import
implement
infect
control
measur
thu
prevent
hospit
rsv
recogn
major
risk
pediatr
ward
human
rsv
reclassifi
speci
human
orthopneumoviru
belong
pneumovirida
famili
genu
orthopneumoviru
rsv
discov
chimpanze
subsequ
confirm
human
pathogen
shortli
thereaft
sever
anim
rsv
genu
human
rsv
infect
human
nonseg
singlestrand
negativesens
rna
genom
kb
length
contain
gene
direct
genom
contain
gene
two
nonstructur
protein
nucleoprotein
np
phosphoprotein
p
matrix
protein
small
hydrophob
protein
sh
attach
glycoprotein
g
fusion
glycoprotein
f
protein
polymeras
l
date
mani
monoclon
antibodi
develop
fusion
protein
rsv
effect
antibodi
rsv
diseas
wide
studi
howev
overal
report
rsv
immunoassay
pool
sensit
specif
confid
interv
ci
ci
respect
polyclon
antibodi
produc
human
rsv
nucleoprotein
np
report
detect
rsv
immunofluoresc
assay
studi
newli
develop
monoclon
antibodi
np
use
develop
immunoassay
clinic
diagnost
perform
immunoassay
evalu
develop
monoclon
antibodi
mab
detect
rsv
nucleoprotein
np
use
fulllength
amino
acid
aa
sequenc
np
genbank
produc
antigen
rsv
np
gene
clone
b
express
e
coli
system
express
rsv
np
antigen
use
purif
result
domin
band
kda
sdspage
western
blot
analysi
use
antihi
tag
antibodi
figur
initi
hybridoma
select
base
reactiv
perform
elisa
cultur
supernat
screen
abil
detect
recombin
antigen
two
hybridoma
produc
secret
antibodi
purifi
test
rsv
viru
reactiv
indirect
elisa
figur
react
rsv
tcid
ml
significantli
bound
rsv
titer
presenc
lysi
buffer
p
viru
detect
either
mab
absenc
presenc
lysi
buffer
character
mab
viral
reactiv
visual
perform
immunofluoresc
assay
ifa
abl
detect
rsv
absenc
suitabl
lysi
buffer
confirm
ifa
shown
figur
investig
sd
ph
lysi
buffer
tri
ethylenediaminetetraacet
acid
edta
triton
sd
ph
found
suitabl
detect
viru
two
antibodi
use
ifa
reactiv
mab
rsv
presenc
lysi
buffer
shown
ifa
figur
presenc
lysi
buffer
posit
signal
rsvinfect
cell
observ
antibodi
commerci
monoclon
antibodi
rsv
np
western
blot
reveal
major
band
kda
indic
reactiv
denatur
rsv
np
figur
isotyp
found
figur
respiratori
syncyti
viru
nucleoprotein
rsvnp
express
e
coli
system
purifi
use
nickel
nitrilotriacet
acid
ninta
agaros
upper
panel
show
sdspage
result
lower
present
western
blot
result
tag
antibodi
marker
bovin
serum
albumin
bsa
supernat
induct
pellet
induct
purifi
rsv
recombin
np
rnp
asterisk
indic
target
band
b
secret
antibodi
supernat
two
hybridoma
test
recombin
np
use
dulbecco
modifi
eagl
medium
dmem
influenza
viru
neg
control
final
purifi
antibodi
test
viru
perform
indirect
elisa
absenc
presenc
lysi
buffer
twoway
anova
p
character
mab
viral
reactiv
visual
perform
immunofluoresc
assay
ifa
abl
detect
rsv
absenc
suitabl
lysi
buffer
confirm
ifa
shown
figur
investig
sd
ph
lysi
buffer
tri
ethylenediaminetetraacet
acid
edta
triton
sd
ph
found
suitabl
detect
viru
two
antibodi
use
ifa
reactiv
mab
rsv
presenc
lysi
buffer
shown
ifa
figur
presenc
lysi
buffer
posit
signal
rsvinfect
cell
observ
antibodi
commerci
monoclon
antibodi
rsv
np
western
blot
reveal
major
band
kda
indic
reactiv
denatur
rsv
np
figur
isotyp
found
figur
respiratori
syncyti
viru
nucleoprotein
rsvnp
express
e
coli
system
purifi
use
nickel
nitrilotriacet
acid
ninta
agaros
upper
panel
show
sdspage
result
lower
present
western
blot
result
tag
antibodi
marker
bovin
serum
albumin
bsa
supernat
induct
pellet
induct
purifi
rsv
recombin
np
rnp
asterisk
indic
target
band
b
secret
antibodi
supernat
two
hybridoma
test
recombin
np
use
dulbecco
modifi
eagl
medium
dmem
influenza
viru
neg
control
final
purifi
antibodi
test
viru
tcid
ml
perform
indirect
elisa
absenc
presenc
lysi
buffer
twoway
anova
p
studi
aim
gener
rapid
fluoresc
diagnost
system
howev
antibodi
appli
rapid
diagnost
strip
perform
fluorescentconjug
antibodi
evalu
fluorescencelink
immunosorb
assay
flisa
figur
schemat
illustr
europium
nanoparticl
eu
np
conjugatebas
fluoresc
immunochromatograph
strip
test
fict
plate
coat
antirsv
npspecif
antibodi
presenc
lysi
buffer
analyt
antigen
viru
appli
well
presenc
eu
npconjug
antirsv
npspecif
antibodi
analyt
detect
measur
fluoresc
intens
determin
perform
flisa
serial
twofold
dilut
rsv
rnp
twofold
dilut
rsv
tcid
ml
use
determin
limit
detect
lod
sandwich
flisa
base
limit
blank
lob
describ
previous
accord
studi
aim
gener
rapid
fluoresc
diagnost
system
howev
antibodi
appli
rapid
diagnost
strip
perform
fluorescentconjug
antibodi
evalu
fluorescencelink
immunosorb
assay
flisa
studi
aim
gener
rapid
fluoresc
diagnost
system
howev
antibodi
appli
rapid
diagnost
strip
perform
fluorescentconjug
antibodi
evalu
fluorescencelink
immunosorb
assay
flisa
analyt
detect
measur
fluoresc
intens
determin
perform
flisa
serial
twofold
dilut
rsv
rnp
twofold
dilut
rsv
use
determin
limit
detect
lod
sandwich
flisa
base
limit
blank
lob
describ
previous
accord
fluoresc
valu
lod
antibodi
pairlink
elisa
rsv
rnp
rsv
figur
perform
sandwich
fluorescencelink
immunosorb
assay
flisa
use
two
novel
monoclon
antibodi
detect
respiratori
syncyti
viru
rsv
sandwich
flisa
use
captur
europium
nanoparticl
eu
np
conjug
detect
conduct
serial
dilut
rsv
recombin
nucleoprotein
rnp
viru
fluoresc
measur
bound
eu
npconjug
excit
nm
emiss
nm
b
serial
dilut
rsv
rnp
antigen
viru
test
flisa
use
neg
viru
control
data
n
shown
mean
sd
au
arbitrari
unit
lod
limit
detect
oneway
anova
p
p
later
flowbas
rapid
diagnost
kit
still
wide
use
conveni
develop
sensit
rapid
method
import
valuabl
studi
typic
later
flow
test
strip
combin
fluoresc
materi
increas
sensit
figur
schemat
illustr
eu
np
conjugatebas
fict
test
strip
fict
conjug
pad
conjug
sampl
pad
applic
sampl
nitrocellulos
membran
antimous
igg
coat
test
line
tl
control
line
cl
respect
perform
diagnost
assay
conjug
eu
np
load
onto
conjug
pad
advanc
presenc
lysi
buffer
conjug
captur
tl
analyt
cl
antimous
igg
recogn
antibodi
conjug
fluoresc
intens
digit
portabl
strip
reader
min
figur
indic
lod
rsv
rnp
viru
fict
display
rsv
rnp
reactiv
good
correl
r
figur
perform
sandwich
fluorescencelink
immunosorb
assay
flisa
use
two
novel
monoclon
antibodi
detect
respiratori
syncyti
viru
rsv
sandwich
flisa
use
captur
europium
nanoparticl
eu
np
conjug
detect
conduct
serial
dilut
rsv
recombin
nucleoprotein
rnp
viru
fluoresc
measur
bound
eu
npconjug
excit
nm
emiss
nm
b
serial
dilut
rsv
rnp
antigen
viru
tcid
ml
test
flisa
use
neg
viru
control
data
n
shown
mean
sd
au
arbitrari
unit
lod
limit
detect
oneway
anova
p
p
later
flowbas
rapid
diagnost
kit
still
wide
use
conveni
develop
sensit
rapid
method
import
valuabl
studi
typic
later
flow
test
strip
combin
fluoresc
materi
increas
sensit
figur
schemat
illustr
eu
np
conjugatebas
fict
test
strip
fict
conjug
pad
conjug
sampl
pad
applic
sampl
nitrocellulos
membran
antimous
igg
coat
test
line
tl
control
line
cl
respect
perform
diagnost
assay
conjug
eu
np
load
onto
conjug
pad
advanc
presenc
lysi
buffer
conjug
captur
tl
analyt
cl
antimous
igg
recogn
antibodi
conjug
fluoresc
intens
digit
portabl
strip
reader
min
figur
indic
lod
rsv
rnp
viru
fict
display
rsv
rnp
reactiv
good
correl
r
show
excel
correl
viru
titer
r
tcid
ml
accord
previou
descript
lod
fict
rsv
rnp
tcid
ml
viru
viru
react
fict
even
high
titer
raw
data
fict
provid
figur
show
excel
correl
viru
titer
r
accord
previou
descript
lod
fict
rsv
rnp
viru
viru
react
fict
even
high
titer
raw
data
fict
provid
figur
compar
perform
fict
molecular
diagnost
method
lod
fict
analyz
base
rna
copi
number
qrtpcr
rna
copi
number
lod
fict
determin
qrtpcr
prepar
viru
viru
sampl
use
rna
extract
calibr
curv
gener
serial
dilut
rna
standard
rsv
np
standard
curv
creat
show
start
copi
number
standard
rna
xaxi
versu
cycl
threshold
ct
yaxi
plot
standard
curv
ct
valu
logarithm
dilut
produc
r
valu
slope
correspond
effici
rang
rsv
np
close
optim
protocol
lod
fict
correspond
ct
valu
mean
sd
rna
copi
numberreact
mixtur
mean
sd
rsv
np
figur
compar
perform
fict
molecular
diagnost
method
lod
fict
analyz
base
rna
copi
number
qrtpcr
rna
copi
number
lod
tcid
ml
fict
determin
qrtpcr
prepar
viru
tcid
ml
viru
sampl
use
rna
extract
calibr
curv
gener
serial
dilut
rna
standard
rsv
np
standard
curv
creat
show
start
copi
number
standard
rna
xaxi
versu
cycl
threshold
ct
yaxi
plot
standard
curv
ct
valu
logarithm
dilut
produc
r
valu
slope
correspond
effici
rang
rsv
np
close
optim
protocol
lod
fict
correspond
ct
valu
mean
sd
rna
copi
numberreact
mixtur
mean
sd
rsv
np
figur
evalu
perform
fict
diagnos
clinic
sampl
nasopharyng
swab
specimen
patient
confirm
rsv
infect
store
wonkwang
univers
hospit
test
rsvposit
patient
rsv
aposit
rsv
bposit
specimen
test
mean
age
rsvposit
patent
eight
femal
twelv
male
month
rang
one
month
month
patient
admit
hospit
tabl
evalu
perform
fict
diagnos
clinic
sampl
nasopharyng
swab
specimen
patient
confirm
rsv
infect
store
wonkwang
univers
hospit
test
rsvposit
patient
rsv
aposit
rsv
bposit
specimen
test
mean
age
rsvposit
patent
eight
femal
twelv
male
month
rang
one
month
month
patient
admit
hospit
tabl
rsvneg
control
group
patient
diseas
includ
unknown
diseas
n
human
metapneumoviru
hmpv
n
parainfluenza
viru
piv
n
ad
n
human
enteroviru
hev
n
human
hrv
n
human
bocaviru
hbov
n
test
patient
coinfect
two
three
differ
virus
mean
age
rsvneg
patent
femal
male
year
rang
one
month
year
patient
admit
hospit
sampl
collect
perform
within
five
day
onset
ill
averag
ct
valu
piv
hmpv
patient
respect
binari
diagnost
decis
tlcl
threshold
cutoff
valu
rsv
determin
base
receiv
oper
characterist
roc
curv
analysi
plot
data
use
graphpad
prism
valu
use
app
posit
tlcl
neg
otherwis
accord
roc
curv
analysi
cutoff
valu
result
highest
clinic
sensit
specif
diagnos
rsv
infect
figur
roc
curv
analysi
result
area
curv
auc
valu
ci
patient
figur
p
figur
raw
data
fict
provid
figur
sensit
fict
assay
compar
pcr
sd
rdt
rsv
evalu
correl
pcr
fict
assay
kappa
statist
calcul
previous
describ
fict
kappa
show
better
correl
pcr
rdt
kappa
tabl
figur
raw
data
fict
provid
figur
sensit
fict
assay
compar
pcr
sd
rdt
rsv
evalu
correl
pcr
fict
assay
kappa
statist
calcul
previous
describ
fict
kappa
show
better
correl
pcr
rdt
kappa
tabl
rsv
common
viral
caus
pediatr
bronchiol
pneumonia
worldwid
infant
month
age
howev
clinic
manifest
rsv
indistinguish
etiolog
acut
respiratori
infect
perform
current
clinic
rsv
rapid
diagnost
kit
approxim
sensit
specif
due
low
sensit
altern
method
improv
biophys
approach
rsv
detect
employ
easytoperform
rapid
diagnost
system
need
current
detect
method
rsv
involv
fluoresc
materi
plasmon
improv
immunoassay
sensit
due
speed
conveni
low
cost
portabl
abil
provid
quantifi
result
applic
fluoresc
materi
could
lead
promis
pointofcar
diagnost
tool
screen
patient
suspect
respiratori
infect
type
infecti
diseas
one
promis
fluoresc
materi
europium
nanoparticl
although
use
influenza
use
rsv
diagnost
system
develop
effect
detect
method
suitabl
target
make
antibodi
need
identifi
fusion
protein
commonli
use
make
antibodi
neutral
rsv
howev
despit
surfac
antigen
fusion
protein
limit
diagnost
target
base
crossreact
paramyxoviru
monoclon
antibodi
studi
search
highli
conserv
protein
identifi
np
report
use
np
diagnost
assay
detect
rsv
although
sensit
satisfactori
case
sensit
lod
report
recent
dna
aptam
detect
rsv
g
protein
report
lod
pfuml
upon
convert
valu
tcid
ml
use
formula
pfu
ml
tcid
ml
higher
perform
fict
lod
tcid
ml
indic
howev
studi
test
spike
viru
specimen
rather
clinic
patient
sampl
sensitivityspecif
sd
rsv
kit
report
compar
rtpcr
sensit
rdt
sd
rsv
develop
studi
consid
sensit
fict
might
higher
commerci
sd
rsv
rdt
assay
sensit
pcrposit
patient
rang
viral
load
respiratori
specimen
rna
copi
per
ml
thu
fict
correspond
rna
copi
numberreact
mixtur
valu
mean
sd
rsv
np
establish
lod
might
use
diagnos
rsv
infect
patient
fict
show
could
detect
rsv
coinfect
specimen
accur
sd
rdt
higher
posit
rate
fict
sd
rdt
howev
fict
abl
detect
rsvb
one
patient
although
cell
cultur
patient
posit
patient
possess
high
amount
rsv
rna
ct
valu
sd
rdt
also
neg
patient
except
patient
fict
abl
detect
rsv
patient
ct
valu
howev
sd
rdt
detect
five
patient
ct
valu
although
pcr
show
high
perform
diagnos
rsv
still
limit
complex
high
cost
furthermor
upper
respiratori
infect
common
winter
month
indic
acut
prior
infect
pathogen
distinguish
pcr
therefor
simpl
rapid
antigendetect
test
offer
potenti
advantag
associ
pointofcar
test
poct
pcr
fict
method
improv
perform
poct
fusion
antigenbas
poct
quickvu
rsv
test
kit
demonstr
sensit
specif
studi
lysi
buffer
indispens
fict
clinic
perform
fict
compar
fusion
antigenbas
quickvu
rsv
kit
lysi
buffer
contain
deterg
sd
effici
antibodi
detect
rsv
limit
studi
small
patient
popul
use
evalu
clinic
perform
fict
thu
studi
need
assess
accuraci
fict
europium
nanoparticl
diamet
purchas
bang
laboratori
inc
fisher
usa
aliphat
amin
latex
bead
diamet
purchas
life
technolog
carlsbad
ca
usa
n
n
ethylcarbodiimid
hydrochlorid
edc
nhydroxysulfosuccinimid
sodium
salt
sulfonh
purchas
thermo
fisher
scientif
waltham
usa
antirsv
fusion
antirsv
nucleoprotein
np
purchas
abcam
cambridg
uk
rabbit
antimous
igg
h
l
horseradish
peroxidas
hrp
goat
antimous
igg
h
l
fict
obtain
abcam
rsv
strain
influenza
viru
strain
obtain
korea
nation
research
resourc
center
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
antibioticantimycot
invitrogen
carlsbad
ca
unit
state
c
co
humidifi
incub
sanyo
osaka
japan
monolay
confluent
cell
infect
rsv
multipl
infect
moi
one
follow
min
incub
supernat
remov
complet
media
ad
cell
follow
incub
c
five
day
tcid
assay
conduct
previous
report
fulllength
gene
encod
rsva
np
genbank
amplifi
pcr
two
pair
primer
includ
forward
primer
gga
tcc
gat
ggc
tct
tag
caa
agt
revers
primer
ctc
gag
cat
agg
ttg
ttc
cct
tca
rsvnp
dna
fragment
subclon
rsv
rnp
antigen
express
induc
mm
isopropyl
total
protein
harvest
purifi
ninta
thermo
fisher
scientif
express
antigen
confirm
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
use
antimous
histag
antibodi
thermo
fisher
scientif
dilut
membran
wash
three
time
incub
secondari
antimous
antibodi
antimous
igg
conjug
horseradish
peroxidas
abcam
dilut
block
buffer
min
room
temperatur
wash
five
time
protein
band
visual
biorad
chemidoc
xr
biorad
hercul
ca
usa
rsv
antigen
test
sd
biolin
abbott
santa
clara
ca
usa
perform
use
nasopharyng
specimen
mix
volum
provid
reagent
rsv
strip
test
ad
mixtur
later
flow
min
result
read
nake
eye
evalu
perform
immunoassay
rsv
qrtpcr
use
np
gene
refer
assay
primer
probe
target
gene
encod
rsv
np
prepar
previous
describ
determin
ct
valu
correspond
lod
fict
qrtpcr
perform
use
quantitect
probe
rtpcr
kit
qiagen
hilden
germani
realtim
pcr
detect
system
produc
standard
determin
rna
copi
number
templat
clone
pgemt
easi
promega
madison
wi
usa
vitro
transcript
reaction
perform
use
ribomax
transcript
kit
promega
studi
approv
wonkwang
univers
hospit
institut
review
board
approv
approv
juli
patient
agre
particip
studi
inform
consent
obtain
obtain
specimen
experi
method
perform
accord
relev
guidelin
regul
nucleic
acid
extract
specimen
use
rneasi
mini
kit
qiagen
mississauga
canada
amplifi
commerci
multiplex
assay
seegen
inc
seoul
korea
rmix
rapid
cell
cultur
method
quidel
san
diego
ca
usa
use
diagnos
specimen
gener
data
provid
mean
standard
deviat
sd
biolog
replic
plot
use
graphpad
prism
graphpad
la
jolla
ca
usa
fict
improv
sensit
convent
rdt
diagnos
rsv
infect
assay
could
help
promptli
identifi
patient
infect
rsv
necessari
treatment
start
immedi
diagnosi
